Skip to content

Management of childhood empyema: is there any abnormal lung-function after surgical intervention?

Management of childhood empyema: is there any abnormal lung-function after surgical intervention? - Lung-function after childhood empyema with surgical intervention

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON30020
Enrollment
60
Registered
2006-08-24
Start date
2006-01-05
Completion date
Unknown
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung empyema pleural empyema

Interventions

None listed

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
2 Years to 99 Years

Inclusion criteria

Inclusion criteria: The empyemas must suffice the next criteria: 'febrile illness with pulmonary dysfunction', 'accumulation of fluid in the pleural space on X-thorax or ultrasound' and 'purulent fluid in pleural space or signs of loculations on X-thorax or ultrasound/ WBC count * 15.000/*l.* Patients have undergone video assited thorocoscopic surgery, decortication or thoracotomy.

Exclusion criteria

Exclusion criteria: Phase 1 empyemas; empyemas caused by trauma, surgery (other than interventional surgery) or tbc; mental retardation, age

Design outcomes

Primary

MeasureTime frame
Primary study parameters of the pulmonary function test: *Total lung capacity (TLC), FEV1/VC Primary study parameter of the exersize test: *VO2 max.

Secondary

MeasureTime frame
Secundary study parameters of the pulmonary function test: *Forced vital capacity (FVC), FEV1, Maximal mid-expiratory flow (MMEF25*75%), Residual volume (RV), diffusion capacity. Secundary study parameters of the exersize test: *heart frequenty max. (HF max.), max. exercise ventilation/max. voluntary ventilation, max. tidal volume/inspiratorycapacity (Vt max/IC), O2 pulse, SO2, respiratory quotiënt (VCO2/VO2).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)